Vitamin D drug may weaken pancreatic cancer shield
Paricalcitol, a modified vitamin D drug, softened pancreatic tumours' barrier in mice, letting immunotherapy work. Trial plans and caveats.
Simple explainers on world affairs, science, health and more.
All news under one minute
Paricalcitol, a modified vitamin D drug, softened pancreatic tumours' barrier in mice, letting immunotherapy work. Trial plans and caveats.
Niacin, a vitamin B3 supplement, slowed glioblastoma in mice by activating immune cells, per a Cell Reports Medicine study. Results and caveats.
A Nature Medicine study found 16 blood molecules linked to menopause that track with Alzheimer's risk, confirmed in 2,800 UK Biobank women.
A Nature Medicine study of 2.5M people found 26 genetic loci linked to fibromyalgia, strongest in the HTT gene, with risk concentrated…
Stablepharma's SPVX02 vaccine stayed stable 24 months at 30C in a 60-adult Southampton trial, published in eClinicalMedicine.
A Northwestern study of 35 volunteers found reaction times 41ms faster during exhalation than inhalation, published in iScience.
A Swedish study of nearly 15,000 people with bipolar disorder found semaglutide use was linked to a 21% lower risk of psychiatric…
University of Iowa researchers say demographics and lifestyle factors explain 76% of excess cases for Iowa's five most common cancers, but hundreds…
Chewing tobacco caused 251,000 deaths in 2023, with India among 10 nations bearing 90% of the burden, says a Lancet study.
The FDA approved the first heart valve that can expand as a child grows, based on a study of 62 children at…